Life expectancy in the United States dropped yet again as drug overdose deaths continued to climb -- taking more than 70,000 lives in 2017 -- and suicides rose, a US government report said Thursday.
The drug overdose rate rose 9.6 per cent compared to 2016, while suicides climbed 3.7 per cent, said the US Centers for Disease Control and Prevention's (CDC) National Center for Health Statistics.
As a result, the average life span in America dropped to "78.6 years, a decrease of 0.1 year from 2016," said the report.
The data comes as the United States grapples with a vast opioid epidemic, fueled by addiction to prescription painkillers as well as street drugs like heroin and synthetic opioids including fentanyl.
"The latest CDC data show that the US life expectancy has declined over the past few years. Tragically, this troubling trend is largely driven by deaths from drug overdose and suicide," said CDC director Robert Redfield.
"Life expectancy gives us a snapshot of the nation's overall health and these sobering statistics are a wakeup call that we are losing too many Americans, too early and too often, to conditions that are preventable."
Overall, the statistics show a "downward trend in life expectancy since 2014," a time period in which Americans have lost 0.3 years of life, he told AFP, describing the trend as "very concerning."
Health and Human Services Secretary Alex Azar said at a health conference in October, when that data came out, that the "seemingly relentless trend of rising overdose deaths seems to be finally bending in the right direction."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
